D.A. Evans et al, Journal of Organic Chemistry, vol. 64, No. 17 Aug. 20, 1999, pp. 6411-6417, “A general method for the synthesis of enantimerically pure beta-substituted, beta-amino acids through alpha-substituted succinic acid derivatives”. |
M. Yamamoto et al., J. of Medicinal Chemistry, No. 8, Apr. 9, 1998, pp. 1209-1217, “Inhibition of membrane—type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket”. |
D.H. Steinman et al. Bioorganic & Medicinal Chemistry Letters vol. 8, No. 16, Aug. 18, 1998, pp. 2087-2092, “The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors”. |
C.B. Vu et al, Bioorganic & Medicinal Chemistry Letters vol. 9, No. 20, Oct. 18, 1999, pp. 3009-3014, “Nonpeptidic SH2 Inhibitors of the Tyrosine Kinase ZAP-70”. |
K. F. McClure et al., Bioorganic & Medicinal Chemistry Letters vol. 8, No. 2, pp. 143-146, “Alkylation of succinates: synthesis of RO 32-3555,”Alkylation of succinates: synthesis of RO 32-3555. |
B. Simoneau, et al., Bioorganic & Medicinal Chemistry Letters vol. 7, No. 3, pp. 489-508, “Discovery of Non-peptidic P2-P3 Butanediamide Renin Inhibitors with High Oral Efficacy”. |
C. D. Floyd et al. SYNLETT, No. 6, Jun. 1998, pp. 637-639, “Rapid synthesis of matrix metalloproteinase inhibitors via Ugi four-component condensation”. |
Abstract, Preparation and fromulation of hydroxamic acid derivatives as matrix metalloproteinase inhibitors, Chemical Abstracts Service, Columbus, OH, Database accession No. 1997:594709, XP002163188. |
International Search Report for PCT/IB001/01855. |